Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | KCNE5 | Human | 17beta-estradiol | decreases expression | ISO | Kcne5 (Mus musculus) | 6480464 | Estradiol results in decreased expression of KCNE5 mRNA | CTD | PMID:19484750 | KCNE5 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of KCNE5 mRNA | CTD | PMID:30165855 | KCNE5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Kcne5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KCNE5 mRNA | CTD | PMID:32109520 | KCNE5 | Human | 4,4'-sulfonyldiphenol | increases methylation | EXP | | 6480464 | bisphenol S results in increased methylation of KCNE5 gene | CTD | PMID:31601247 | KCNE5 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Kcne5 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of KCNE5 mRNA | CTD | PMID:24780913 and PMID:25825206 | KCNE5 | Human | acetamide | increases expression | ISO | Kcne5 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of KCNE5 mRNA | CTD | PMID:31881176 | KCNE5 | Human | acrylamide | affects expression | ISO | Kcne5 (Rattus norvegicus) | 6480464 | Acrylamide affects the expression of KCNE5 mRNA | CTD | PMID:28959563 | KCNE5 | Human | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of KCNE5 mRNA | CTD | PMID:19774075 | KCNE5 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of KCNE5 mRNA | CTD | PMID:33212167 | KCNE5 | Human | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of KCNE5 mRNA | CTD | PMID:22378314 | KCNE5 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of KCNE5 3' UTR more ... | CTD | PMID:27901495 | KCNE5 | Human | bisphenol A | increases expression | ISO | Kcne5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of KCNE5 mRNA | CTD | PMID:30951980 | KCNE5 | Human | bisphenol A | increases methylation | ISO | Kcne5 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of KCNE5 gene | CTD | PMID:28505145 | KCNE5 | Human | bisphenol A | decreases methylation | ISO | Kcne5 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of KCNE5 promoter | CTD | PMID:27312807 | KCNE5 | Human | bisphenol A | decreases expression | ISO | Kcne5 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of KCNE5 mRNA | CTD | PMID:25181051 and PMID:27178563 | KCNE5 | Human | bisphenol F | increases expression | ISO | Kcne5 (Mus musculus) | 6480464 | bisphenol F results in increased expression of KCNE5 mRNA | CTD | PMID:30951980 | KCNE5 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of KCNE5 mRNA | CTD | PMID:25979313 | KCNE5 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to KCNE5 gene] | CTD | PMID:28238834 | KCNE5 | Human | Cuprizon | decreases expression | ISO | Kcne5 (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of KCNE5 mRNA | CTD | PMID:27523638 | KCNE5 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of KCNE5 mRNA | CTD | PMID:27989131 | KCNE5 | Human | genistein | increases expression | ISO | Kcne5 (Mus musculus) | 6480464 | Genistein results in increased expression of KCNE5 mRNA | CTD | PMID:32186404 | KCNE5 | Human | glycidol | decreases expression | ISO | Kcne5 (Rattus norvegicus) | 6480464 | glycidol results in decreased expression of KCNE5 mRNA | CTD | PMID:24915197 | KCNE5 | Human | GW 4064 | decreases expression | ISO | Kcne5 (Mus musculus) | 6480464 | GW 4064 results in decreased expression of KCNE5 mRNA | CTD | PMID:26655953 | KCNE5 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of KCNE5 mRNA | CTD | PMID:23557933 | KCNE5 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of KCNE5 mRNA | CTD | PMID:25895662 | KCNE5 | Human | titanium dioxide | decreases expression | ISO | Kcne5 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of KCNE5 mRNA | CTD | PMID:29264374 | KCNE5 | Human | titanium dioxide | increases methylation | ISO | Kcne5 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of KCNE5 gene | CTD | PMID:35295148 | KCNE5 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of KCNE5 gene | CTD | PMID:29154799 | KCNE5 | Human | valproic acid | affects expression | ISO | Kcne5 (Mus musculus) | 6480464 | Valproic Acid affects the expression of KCNE5 mRNA | CTD | PMID:17292431 | KCNE5 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of KCNE5 mRNA | CTD | PMID:25979313 | |